FDA inspection
Penta Fine Ingredients, Inc.: FDA inspection ending Feb 16, 2024
FDA inspection 1231026 · Official Action Indicated (OAI) · West Caldwell, NJ
Key facts
| Inspection ID | 1231026 |
|---|---|
| Firm | Penta Fine Ingredients, Inc. |
| FEI number | 2246566 |
| Address | 4 Dedrick Pl |
| City | West Caldwell |
| State | NJ |
| ZIP | 07006 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Feb 16, 2024 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data